Better health-related quality of life is associated with prolonged survival and reduced hospitalization risk among dialysis-dependent chronic kidney disease patients: a historical cohort study.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
31 Oct 2024
Historique:
received: 12 04 2024
accepted: 23 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

End-stage kidney disease (ESKD) negatively affects patients' physical, emotional, and social functioning. Furthermore, adjustment to dialysis require substantial lifestyle changes that may further impact on patients physical and emotional well-being. However, the relationship between Health-Related Quality of life impairment with future adverse outcomes in dialysis is not well characterized. Our study aims to investigate the relationship between Health-Related Quality of Life (HRQoL) and patients' survival and hospitalization rates within a large European dialysis network. A historical cohort study was conducted to evaluate association of HRQoL with hospitalization and mortality rates over a 12-month follow-up period. Patients responded to a self-administered survey as part of a Continuous Quality Improvement Program implemented in clinics affiliated with the Spanish FMC-Nephrocare organization. Health-Related Quality of Life (HRQoL) was measured with the KDQOL-36. Potential confounders included socio-demographic characteristics, comorbidities, biochemical parameters, dialysis treatment. We used Cox's Proportional Hazard regression to assess the hazard of death and Logistic Regression to assess the likelihood of hospital admissions during 12-month follow-up period. A total of 2280 (51.5%) completed the self-administrated survey, and 1838 patients met the inclusion/exclusion criteria of the study. Higher HRQoL scores were associated with significantly lower mortality and hospitalization risk. Risk estimates were robust to adjustment for potential confounders. Several dimensions of HRQoL are associated with patient-centered outcomes (i.e., mortality and hospitalizations at 1 year). Patient-Reported Outcomes contribute unique pieces of information characterizing patients' health. Residual confounding cannot be fully ruled out; moreover, the high attrition rate could result in selection bias, which may limit the generalizability of the findings to a broader population.

Identifiants

pubmed: 39482605
doi: 10.1186/s12882-024-03835-0
pii: 10.1186/s12882-024-03835-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

388

Informations de copyright

© 2024. The Author(s).

Références

Kittiskulnam P, Sheshadri A, Johansen KL. <ArticleTitle Language=“En”>Consequences of CKD on Functioning. Semin Nephrol. 2016;36(4):305–18. https://doi.org/10.1016/j.semnephrol.2016.05.007 .
doi: 10.1016/j.semnephrol.2016.05.007 pubmed: 27475661 pmcid: 4967875
Sharma S, Kalra D, Rashid I, et al. Assessment of Health-Related Quality of Life in Chronic Kidney Disease Patients: A Hospital-Based Cross-Sectional Study. Med. 2023;59(10). https://doi.org/10.3390/medicina59101788 .
Chuasuwan A, Chuasuwan A, Pooripussarakul S, et al. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: A systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18(1):1–11. https://doi.org/10.1186/s12955-020-01449-2 .
doi: 10.1186/s12955-020-01449-2
Brown EA, Zhao J, McCullough K, et al. Burden of Kidney Disease, Health-Related Quality of Life, and Employment Among Patients Receiving Peritoneal Dialysis and In-Center Hemodialysis: Findings From the DOPPS Program. Am J Kidney Dis. 2021;78(4):489–e5001. https://doi.org/10.1053/j.ajkd.2021.02.327 .
doi: 10.1053/j.ajkd.2021.02.327 pubmed: 33872688
Raoofi S, Pashazadeh Kan F, Rafiei S, et al. Hemodialysis and peritoneal dialysis-health-related quality of life: systematic review plus meta-analysis. BMJ Support Palliat Care. 2023;13:365–73. https://doi.org/10.1136/bmjspcare-2021-003182 .
doi: 10.1136/bmjspcare-2021-003182 pubmed: 34301643
Mapes DL, Lopes AA, Satayathum S et al. Health-Related Quality of Life as a Predictor of Mortality and Hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Vol 64.; 2003. https://doi.org/10.1046/j.1523-1755.2003.00072.x
Pei M, Aguiar R, Pagels AA et al. Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study. https://doi.org/10.1186/s12882-019-1318-x
Peipert JD, Nair D, Klicko K, Schatell DR, Hays RD. Kidney disease quality of life 36-item short form survey (KDQOL-36) normative values for the United States dialysis population and new single summary score. J Am Soc Nephrol. 2019;30(4):654–63. https://doi.org/10.1681/ASN.2018100994 .
doi: 10.1681/ASN.2018100994 pubmed: 30898868 pmcid: 6442334
Tong A, Manns B, Hemmelgarn B, et al. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysis. Trials. 2015;16(1). https://doi.org/10.1186/s13063-015-0895-7 .
Official JOurnal Of the InternatiOnal SOciety Of NephrOlOgy KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Garbelli M, Ion Titapiccolo J, Bellocchio F, Stuard S, Brancaccio D, Neri L. Prolonged patient survival after implementation of a continuous quality improvement programme empowered by digital transformation in a large dialysis network. Nephrol Dial Transpl. 2022;37(3):469–76. https://doi.org/10.1093/ndt/gfab160 .
doi: 10.1093/ndt/gfab160
Neri L, Ponce P, Matias N, Stuard S, Cromm K. Clinical target achievement is associated with better quality of life among dialysis patients: results from a continuous quality improvement program in a Portuguese healthcare network. Qual Life Res. 2020;29(10):2705–14. https://doi.org/10.1007/s11136-020-02543-0 .
doi: 10.1007/s11136-020-02543-0 pubmed: 32654053
Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16(10). https://doi.org/10.1038/s41581-020-0315-4 .
Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols. JAMA. 2018;319(5):483. https://doi.org/10.1001/jama.2017.21903 .
doi: 10.1001/jama.2017.21903 pubmed: 29411037
Nair D, Wilson FP. Patient-Reported Outcome Measures for Adults With Kidney Disease: Current Measures, Ongoing Initiatives, and Future Opportunities for Incorporation Into Patient-Centered Kidney Care. Am J Kidney Dis. 2019;74(6):791–802. https://doi.org/10.1053/j.ajkd.2019.05.025 .
doi: 10.1053/j.ajkd.2019.05.025 pubmed: 31492487 pmcid: 6875620
Burns DJP, Arora J, Okunade O, et al. International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients. JACC Hear Fail. 2020;8(3):212–22. https://doi.org/10.1016/j.jchf.2019.09.007 .
doi: 10.1016/j.jchf.2019.09.007
Perl J, Karaboyas A, Morgenstern H, et al. Association between changes in quality of life and mortality in hemodialysis patients: Results from the DOPPS. Nephrol Dial Transpl. 2017;32(3):521–7. https://doi.org/10.1093/ndt/gfw233 .
doi: 10.1093/ndt/gfw233
Boyce MB, Browne JP. Does providing feedback on patient-reported outcomes to healthcare professionals result in better outcomes for patients? A systematic review. Qual Life Res. 2013;22(9):2265–78. https://doi.org/10.1007/s11136-013-0390-0 .
doi: 10.1007/s11136-013-0390-0 pubmed: 23504544
van der Willik EM, Hemmelder MH, Bart HAJ, et al. Routinely measuring symptom burden and health-related quality of life in dialysis patients: first results from the Dutch registry of patient-reported outcome measures. Clin Kidney J. 2021;14(6):1535–44. https://doi.org/10.1093/ckj/sfz192 .
doi: 10.1093/ckj/sfz192 pubmed: 34285801
Basch E, Deal AM, Dueck AC, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017;318(2):197. https://doi.org/10.1001/jama.2017.7156 .
doi: 10.1001/jama.2017.7156 pubmed: 28586821
Greenhalgh J, Gooding K, Gibbons E, et al. How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? a realist synthesis. J Patient-Reported Outcomes. 2018;2. https://doi.org/10.1186/s41687-018-0061-6 .
Evans JM, Glazer A, Lum R, et al. Implementing a patient-reported outcome measure for hemodialysis patients in routine clinical care perspectives of patients and providers on esas-r:Renal. Clin J Am Soc Nephrol. 2020;15(9):1299–309. https://doi.org/10.2215/CJN.01840220 .
doi: 10.2215/CJN.01840220 pubmed: 32843371 pmcid: 7480546
Valderas JM, Kotzeva A, Espallargues M, et al. The impact of measuring patient-reported outcomes in clinical practice: A systematic review of the literature. Qual Life Res. 2008;17(2). https://doi.org/10.1007/s11136-007-9295-0 .
Aiyegbusi OL, Nair D, Peipert JD, Schick-Makaroff K, Mucsi I. A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases. Ther Adv Chronic Dis. 2021;12. https://doi.org/10.1177/20406223211015958 .
Anderson NE, McMullan C, Calvert M, et al. Using patient-reported outcome measures during the management of patients with end-stage kidney disease requiring treatment with haemodialysis (PROM-HD): A qualitative study. BMJ Open. 2021;11(8). https://doi.org/10.1136/bmjopen-2021-052629 .
Lopes AA, Bragg-Gresham JL, Satayathum S, et al. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2003;41(3):605–15. https://doi.org/10.1053/ajkd.2003.50122 .
doi: 10.1053/ajkd.2003.50122 pubmed: 12612984
Mapes DL, Lopes AA, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: The dialysis outcomes and practice patterns study (DOPPS). Kidney Int. 2003;64(1):339–49. https://doi.org/10.1046/j.1523-1755.2003.00072.x .
doi: 10.1046/j.1523-1755.2003.00072.x pubmed: 12787427
Roshanravan B, Khatri M, Robinson-Cohen C, et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis. 2012;60(6):912–21. https://doi.org/10.1053/j.ajkd.2012.05.017 .
doi: 10.1053/j.ajkd.2012.05.017 pubmed: 22770927 pmcid: 3491110
Chowdhury R, Peel NM, Krosch M, Hubbard RE. Frailty and chronic kidney disease: A systematic review. Arch Gerontol Geriatr. 2017;68:135–42. https://doi.org/10.1016/j.archger.2016.10.007 .
doi: 10.1016/j.archger.2016.10.007 pubmed: 27810661
DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30(2):204–12. https://doi.org/10.1016/S0272-6386(97)90053-6 .
doi: 10.1016/S0272-6386(97)90053-6 pubmed: 9261030
Neri L, Kreuzberg U, Bellocchio F, et al. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: A historical cohort study. Nephrol Dial Transpl. 2019;34(4):682–91. https://doi.org/10.1093/ndt/gfy273 .
doi: 10.1093/ndt/gfy273
Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol. 2001;12(12). https://doi.org/10.1681/asn.v12122797 .
Vilagut G, Forero CG, Pinto-Meza A, et al. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: Results with three alternative scoring methods. Value Heal. 2013;16(4):564–73. https://doi.org/10.1016/j.jval.2013.01.006 .
doi: 10.1016/j.jval.2013.01.006
Drayer RA, Piraino B, Reynolds CF, et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry. 2006;28(4):306–12. https://doi.org/10.1016/J.GENHOSPPSYCH.2006.03.008 .
doi: 10.1016/J.GENHOSPPSYCH.2006.03.008 pubmed: 16814629
Muthukumaran A, Natarajan G, Thanigachalam D, Sultan SA, Jeyachandran D, Ramanathan S. The Role of Psychosocial Factors in Depression and Mortality Among Urban Hemodialysis Patients. Kidney Int Rep. 2021;6(5):1437. https://doi.org/10.1016/J.EKIR.2021.02.004 .
doi: 10.1016/J.EKIR.2021.02.004 pubmed: 34013122 pmcid: 8116760
Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV. Association Between Depression and Mortality in Patients Receiving Long-term Dialysis: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2014;63(4):623–35. https://doi.org/10.1053/J.AJKD.2013.08.024 .
doi: 10.1053/J.AJKD.2013.08.024 pubmed: 24183836
Neri L, Brancaccio D, Rocca Rey LA, Rossa F, Martini A, Andreucci VE. Social support from health care providers is associated with reduced illness intrusiveness in hemodialysis patients. Clin Nephrol. 2011;75(2):125–34. https://doi.org/10.5414/CNP75125 .
doi: 10.5414/CNP75125 pubmed: 21255542
Ling C, Evans D, Zhang Y, et al. The effects of cognitive behavioural therapy on depression and quality of life in patients with maintenance haemodialysis: A systematic review. BMC Psychiatry. 2020;20(1). https://doi.org/10.1186/s12888-020-02754-2 .
Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20(3):645–54. https://doi.org/10.1681/ASN.2008060590 .
doi: 10.1681/ASN.2008060590 pubmed: 19092122 pmcid: 2653681
Rocco MV, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080–91. https://doi.org/10.1038/KI.2011.213 .
doi: 10.1038/KI.2011.213 pubmed: 21775973
Ryom Oh T, Sang Choi H, Kim S et al. Association between health related quality of life and progression of chronic kidney disease. https://doi.org/10.1038/s41598-019-56102-w
Mujais SK, Story K, Brouillette J, et al. Health-related quality of Life in CKD patients: Correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4(8):1293–301. https://doi.org/10.2215/CJN.05541008 .
doi: 10.2215/CJN.05541008 pubmed: 19643926
Kefale B, Alebachew M, Tadesse Y, Engidawork E. Quality of life and its predictors among patients with chronic kidney disease: A hospital-based cross sectional study. PLoS ONE. 2019;14(2):e0212184. https://doi.org/10.1371/JOURNAL.PONE.0212184 .
doi: 10.1371/JOURNAL.PONE.0212184 pubmed: 30811447
Porter AC, Lash JP, Xie D, et al. Predictors and outcomes of health-related quality of life in adults with CKD. Clin J Am Soc Nephrol. 2016;11(7):1154–62. https://doi.org/10.2215/CJN.09990915/-/DCSUPPLEMENTAL .
doi: 10.2215/CJN.09990915/-/DCSUPPLEMENTAL pubmed: 27246012
Gorodetskaya I, Zenios S, McCulloch CE, et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005;68(6):2801–8. https://doi.org/10.1111/J.1523-1755.2005.00752.X .
doi: 10.1111/J.1523-1755.2005.00752.X pubmed: 16316356
Neri L, Dukes J, Brennan DC, et al. Impaired renal function is associated with worse self-reported outcomes after kidney transplantation. Qual Life Res. 2011;20(10):1689–98. https://doi.org/10.1007/S11136-011-9905-8/METRICS .
doi: 10.1007/S11136-011-9905-8/METRICS pubmed: 21479956
Neri L, McEwan P, Sennfält K, Baboolal K. Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: A cross-sectional study. Health Qual Life Outcomes. 2012;10(1):1–8. https://doi.org/10.1186/1477-7525-10-139/FIGURES/2 .
doi: 10.1186/1477-7525-10-139/FIGURES/2
Pagels AA, Stendahl M, Evans M. Patient-reported outcome measures as a new application in the Swedish Renal Registry: health-related quality of life through RAND-36. Clin Kidney J Published online. 2019. https://doi.org/10.1093/ckj/sfz084 .
doi: 10.1093/ckj/sfz084
Duncanson E, Bennett PN, Viecelli A, et al. Feasibility and acceptability of e-PROMs data capture and feedback among patients receiving haemodialysis in the Symptom monitoring with Feedback Trial (SWIFT) pilot: Protocol for a qualitative study in Australia. BMJ Open. 2020;10(11). https://doi.org/10.1136/bmjopen-2020-039014 .

Auteurs

Abraham Rincon Bello (A)

Fresenius Medical Care, Nephrocare, Madrid, Spain.

Jasmine Ion Titapiccolo (J)

Data Science Division - Clinical Advanced Analytics, Global Medical Office - Fresenius Medical Care, Vaiano Cremasco, Italy.

Isabel Berdud Godoy (I)

Fresenius Medical Care, Nephrocare, Madrid, Spain.

Diana J C Samaniego (DJC)

Fresenius Medical Care, Nephrocare, Madrid, Spain.

Sofia Ortego Perez (S)

Fresenius Medical Care, Nephrocare, Madrid, Spain.

Alicia Sobrino Perez (A)

Fresenius Medical Care, Nephrocare, Madrid, Spain.

Kateryna Shkolenko (K)

Fresenius Medical Care, Nephrocare, Madrid, Spain.

Stefano Stuard (S)

EMEA Chief Clinical Officer, Global Medical Office - Clinical Affairs, CoE Clinical & Therapeutic Governance - Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.

Luca Neri (L)

Data Science Division - Clinical Advanced Analytics, Global Medical Office - Fresenius Medical Care, Vaiano Cremasco, Italy. luca.neri@fmc-ag.com.

Maria Eva Baró Salvador (ME)

Fresenius Medical Care, Nephrocare, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH